BackRecursion Pharmaceuticals Overview

Recursion Pharmaceuticals Goodwill

Recursion Pharmaceuticals's goodwill is $160M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$160.35M
↓ 2.39% YoYΔ $-3.92M vs prior year quarter

Peer trimmed avg / median

Loading

Recursion Pharmaceuticals Goodwill History

Loading

Recursion Pharmaceuticals vs. peers: Goodwill Comparison

Loading

Recursion Pharmaceuticals Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Recursion Pharmaceuticals (RXRX) FAQ

As of the most recent data (June 2026), RXRX shows a goodwill of $160M. That compares with $160M in the prior-year period — down 2.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RXRX's goodwill is now $160M (was $160M) — a 2.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Recursion Pharmaceuticals is outperforming or lagging.

Tracking RXRX's goodwill over time shows whether Recursion Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $160M That compares with $160M in the prior-year period — down 2.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Recursion Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $160M) with ownership activity and broader fundamentals.

Recursion Pharmaceuticals's goodwill is $160M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.